Molecular modeling study of 4-phenylpiperazine and 4-phenyl-1,2,3,6-tetrahydropyridine derivatives: a new step towards the design of high-affinity 5-HT1A ligands

Bioorg Med Chem Lett. 2010 Feb 1;20(3):1118-23. doi: 10.1016/j.bmcl.2009.12.027. Epub 2009 Dec 6.

Abstract

The main feature of many drugs having a 5-HT(1A) affinity is the presence of an arylpiperazine moiety. Indeed, the protonated nitrogen and the aromatic ring of the arylpiperazine compounds are considered crucial for the interaction with the receptor. However, the replacement of the piperazine moiety by a 1,2,3,6-tetrahydropyridine ring in 4-arylpiperazine-ethyl carboxamide derivatives was recently shown to be highly favourable for 5-HT(1A) affinity. In order to better understand the favourable effect of this chemical modification, we performed a conformational analysis of these compounds mainly based on the position of the phenyl ring relative to the piperazine and tetrahydropyridine moiety. In the piperazine compounds, the phenyl ring preferentially adopts a perpendicular orientation, whereas an almost planar orientation seems to be the most favourable conformation for the tetrahydropyridine compounds. Therefore, this conformational difference appears as a key for a better interaction with the receptor binding site. This result will serve for the designing high-affinity 5-HT(1A) ligands.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / chemical synthesis
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / chemistry*
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / metabolism*
  • Drug Design*
  • Indoles / chemistry*
  • Indoles / metabolism*
  • Ligands
  • Models, Molecular*
  • Protein Binding / physiology
  • Pyridines / chemistry*
  • Pyridines / metabolism*
  • Receptor, Serotonin, 5-HT1A / chemistry*
  • Receptor, Serotonin, 5-HT1A / metabolism*

Substances

  • DR-4004
  • Indoles
  • Ligands
  • Pyridines
  • Receptor, Serotonin, 5-HT1A
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine